In Brief
ILC3s maintain healthy organ function in the intestine, but how ILC3s directly detect environmental cues is poorly understood. Emgå rd et al. find that GPR183 and oxysterols control the localization and LTi function of ILC3s and thereby promote the formation of colonic lymphoid tissues in the steady state and inflammation.
INTRODUCTION
Innate lymphoid cells (ILCs) are recently described immune cells of lymphoid origin and include cytotoxic natural killer (NK) cells and interleukin-7 receptor alpha (also known as CD127) + subsets, which, similar to T helper (Th) lymphocytes, can be distinguished on the basis of signature transcription factors and effector cytokines: (1) ILC1s require the transcription factor T-BET and produce interferon-g. (2) ILC2s express the transcription factor GATA3 and produce the type 2 cytokines interleukin 5 (IL-5) and ILC3s are dependent on the transcription factor RAR-related orphan receptor gamma t (RORgt) and have the ability to produce IL-17 and/or IL-22. ILC3s are enriched in the intestine, where they maintain healthy tissue function by orchestrating lymphoid-organ development, containment of commensal bacteria, tissue repair, host defense, and regulation of adaptive immunity (Artis and Spits, 2015; Diefenbach et al., 2014; Eberl et al., 2015; McKenzie et al., 2014; Serafini et al., 2015; Sonnenberg and Artis, 2015) . ILC3s can be divided into two main populations with distinct ontogeny, transcriptional programs, and localization within the gut: (1) C-C motif chemokine receptor 6 (CCR6) À ILC3s coexpressing RORgt and T-BET are mainly found scattered throughout the lamina propria (Luci et al., 2009; Sanos et al., 2009; Satoh-Takayama et al., 2008) . (2) CCR6 + NKp46 À fetal lymphoid tissue inducer (LTi) and adult LTi-like cells expressing c-KIT (also known as CD117) seed the gut during fetal development, develop along a pathway distinct from that of other ILCs, and promote lymphoid tissue development Mebius et al., 1997; Sawa et al., 2010) . Accordingly, LTi cells reside in intestinal lymphoid structures, called cryptopatches (CPs) (Kanamori et al., 1996) and isolated lymphoid follicles (ILFs) (Hamada et al., 2002) , which are collectively referred to as solitary intestinal lymphoid tissues (SILTs) (Buettner and Lochner, 2016; Randall and Mebius, 2014) . CPs are clusters of LTi-like ILC3s surrounded by dendritic cells (DCs) within a network of stromal cells, whereas ILFs additionally contain B cells. CPs and ILFs develop postnatally through the activity of adult LTi-like ILC3s that produce lymphotoxin Kruglov et al., 2013; Tsuji et al., 2008) . Whereas lymphoid organogenesis in the small intestine has been well studied, the specific factors required for SILT development in the colon, beyond lymphotoxin, are unknown. Environmental cues, such as microbial, dietary, and neuronal signals, regulate the differentiation and function of ILC3s. However, the identities of any additional cues and the receptors that detect them remain unknown. An important class of proteins enabling cells to sense extracellular cues are G-protein-coupled receptors (GPCRs), which mediate cellular responses to diverse environmental signals. We therefore hypothesized that ILC3 function is regulated by GPCRs that recognize endogenous metabolites. In this regard, we focused on G-protein-coupled receptor 183 (GPR183, also known as EBI2), a GPCR that instructs antibody (Ab) responses in lymphoid organs through the positioning of B cells, T cells, and DCs (Gatto et al., 2009; Gatto et al., 2013; Li et al., 2016; Pereira et al., 2009; Yi and Cyster, 2013) . GPR183 is a receptor for oxysterols (Hannedouche et al., 2011; Liu et al., 2011) , hydroxylated metabolites of cholesterol, which have pleiotropic roles in lipid metabolism, immunity, and inflammation (Cyster et al., 2014) . The most potent GPR183 ligand is 7a, . Synthesizing 7a,25-OHC from cholesterol requires the enzymes cholesterol 25-hydroxylase (CH25H) and cytochrome P450, family 7, subfamily b, polypeptide 1 (CYP7B1), whereas hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid delta-isomerase 7 (HSD3B7) metabolizes 7a,25-OHC into bile acid precursors that lack GPR183 ligand activity. Given that GPR183 regulates immune cell migration, we reasoned that oxysterols could function as guidance cues for ILC3s.
Here, we report that ILC3s sensed oxysterols through GPR183, which was highly expressed by LTi-like ILC3s. 7a,25-OHC-synthesizing enzymes were produced by fibroblastic stromal cells found in intestinal lymphoid structures, and the GPR183 ligand 7a,25-OHC acted as a chemoattractant for ILC3s. GPR183 and 7a,25-OHC were required for ILC3 localization to lymphoid structures in the colon, and ablation of Gpr183 in ILC3s caused a defect in the formation of colonic CPs and ILFs. The same phenotype was observed in mice lacking Ch25h, demonstrating a requirement for oxysterols in lymphoid tissue organogenesis. Furthermore, 7a,25-OHC was increased by inflammatory signals, and GPR183 controlled inflammatory cell recruitment during colitis. Consequently, Gpr183-deficient mice were less susceptible to colitis in an innate model of intestinal inflammation. Our results establish a role for a lipid ligand and its cell-surface receptor in controlling ILC3 migration, lymphoid tissue development, and inflammatory responses in the intestine. 
RESULTS

LTi
CD4
+ ) abundantly expressed Gpr183 (Figure 1A) . To confirm these findings, we used Gpr183 GFP/+ reporter mice (Pereira et al., 2009 ) and focused on the colon, given that it has the full spectrum of ILC subsets ( Figure S1 ). As in the spleen, NK cells largely lacked Gpr183 mRNA, whereas other ILC types expressed Gpr183 ( Figure 1B ). Among all ILC subsets, CD4 + LTilike ILC3s had the highest Gpr183 expression (Figures 1B and 1C) . ILC3s from the small intestine ( Figures S2A-S2C ) and lymph node ( Figure S2D ) also expressed Gpr183. Moreover, mRNA for the GPR183 ligand-regulating enzymes CH25H, CYP7B1, and HSD3B7 was expressed in both the small intestine and colon ( Figure S2E ). The high Gpr183 mRNA expression in LTi-like ILC3s led us to ask whether ILC3s express functional GPR183 on the cell surface. To address this question, we performed chemotaxis assays to the known GPR183 ligand 7a,25-OHC. Splenic LTi-like ILC3s showed a typical bell-shaped chemotactic response to 7a,25-OHC ( Figure 1D ), demonstrating that GPR183 is functional in ILC3s. Consistent with high Gpr183 expression ( Figure S2F ), splenic CD4 + LTi-like ILC3s showed a greater migratory response than other cells to 7a,25-OHC ( Figure 1E ). Colonic ILC3s and ILC2s also migrated toward 7a,25-OHC in vitro ( Figure 1F ). To confirm that 7a,25-OHC drives ILC3 migration through GPR183, we examined the chemotaxis of Gpr183-deficient ILCs. For this purpose, we generated Gpr183
mice. LTi-like ILC3s lacking Gpr183 failed to migrate toward 7a,25-OHC ( Figure 1D ), indicating that ILC3 chemotaxis to oxysterol is GPR183 dependent. We concluded that high GPR183 expression enabled LTi-like ILC3s to migrate toward the chemoattractant oxysterol 7a,25-OHC. Figure 2A ). The fact that ILC3s with LTi function highly expressed GPR183 led us to hypothesize that GPR183 is required for the development of intestinal lymphoid structures. To explore this hypothesis, we crossed Gpr183 À/À mice with Rorc(gt) GFP transgenic mice to visualize and quantify SILTs in frozen sections. Consistent with our hypothesis, the number of CPs and ILFs was markedly lower in the colon of mice lacking Gpr183 than in co-housed Gpr183 +/+ littermates ( Figure 2B ). Moreover, the number of colonic patches was also significantly lower in Gpr183-deficient mice ( Figure 2C ). In contrast, CPs and ILFs were present in the small intestine of Gpr183 À/À mice ( Figure 2B ).
GPR183 Expression by
GPR183 was also dispensable for the development of peripheral and mesenteric lymph nodes, as well as Peyer's patches ( Figure 2C ). To confirm that GPR183 expression in hematopoietic cells was required for CP and ILF formation, we generated bone marrow chimeras. We found that the transfer of Gpr183 +/+ bone marrow into Gpr183-deficient recipients partially rescued SILT development in the colon ( Figure 2D ). A full rescue was not expected because LTi-like ILC3s, in contrast to B cells, are partially radioresistant, which created a mixed ILC3 compartment, consisting of donor-derived Gpr183 +/+ and radioresistant Gpr183-deficient ILC3s of host origin ( Figure S3 ). The reduction of both CPs and ILFs in Gpr183 À/À mice suggested that GPR183 expression on ILC3s, rather than on B cells, was required for colonic lymphoid tissue development. To exclude a role of B-cell-expressed GPR183, we bred Gpr183 À/À mice onto a Rag1-deficient background. The number of colonic CPs was significantly lower in Rag1-and Gpr183-double deficient mice than in Rag1-deficient Gpr183-sufficient mice ( Figure 2E ). Our finding that ILC2s expressed Gpr183 mRNA ( Figure 1B ) and migrated toward 7a,25-OHC ( Figure 1F ) allowed us to predict that ILC2s also reside in colonic lymphoid structures. We confirmed this prediction by staining with a-GATA3 ( Figure S4A ) and a-KLRG1 antibodies (Abs) ( Figure S4B ). To determine whether ILC3-expressed GPR183 was required for CP and ILF formation, we generated Rorc-cre Gpr183 flox/flox mice, where
Gpr183 expression was ablated in ILC3. In these mice, T cells also lacked Gpr183, but T cells are known to be dispensable for lymphoid tissue formation in the intestine (Kiss et al., 2011; Tsuji et al., 2008) . We found that CP and ILF development in the colon, but not in the small intestine, was severely impaired in Rorc-cre Gpr183 flox/flox mice, whereas Peyer's and colonic patches were not affected ( Figure 2F ). Collectively, our data demonstrate that GPR183-expressing cells reside in gut lymphoid structures and that GPR183 expression by ILC3s is crucial for the formation of CPs and ILFs in the colon.
GPR183 and 7a,25-OHC Promote ILC Localization to CPs Next, we wanted to establish how GPR183 regulates CP and ILF formation in the colon. On the basis of the fact that GPR183 controls immune cell migration, we asked whether GPR183 is required for ILC3 recruitment to CPs. To address this question, we generated mixed bone marrow chimeras by sub-lethally irradiating Rag1-deficient mice (CD45.1 + ) and reconstituting them with a 9:1 mixture of Gpr183
) and C57BL/6 (B6) (CD45.1 + ) bone marrow cells ( Figure S5A ). This experimental setup allowed us to study Gpr183-deficient and -sufficient cells in the same environment, thereby excluding any cell-extrinsic effects on cell distribution. As expected, CPs and ILFs in mixed Gpr183 +/+ -B6 chimeras consisted mainly of CD45.2 + Gpr183 +/+ cells ( Figure 3A ). In contrast, Gpr183-deficient hematopoietic cells failed to localize to CPs and ILFs in mixed Gpr183
À/À -B6 chimeras, and accordingly, CPs and ILFs (C) Number of peripheral and mesenteric lymph node cells (n = 6-8), Peyer's patches (n = 10), and colonic patches (n = 3) from Gpr183 +/+ and Gpr183 À/À mice.
(D) Number of RORgt + clusters in the colon of bone marrow chimeras (n = 5-9). Bone marrow cells from Gpr183 +/+ or Gpr183 À/À mice were injected into either
(E) Number of CPs in the colon of Rag1-deficient Gpr183 +/+ and Gpr183 À/À mice (n = 5).
(F) Number of CPs, ILFs, Peyer's patches, and colonic patches in Rorc-cre Gpr183 flox/flox mice and Gpr183 flox/flox or Gpr183 flox/+ controls (n = 3-6).
Data are represented as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0. in these chimeras mostly contained CD45.1 + B6 cells ( Figure 3A ). To more specifically address whether ILC3 migration to CPs and ILFs is dependent on GPR183, we employed a similar mixed bone marrow chimera approach, by using the congenic marker CD90 (Thy1) instead of CD45 ( Figure S5B ), given that CD90 labels ILCs more specifically than CD45. Notably, donor-derived Gpr183 À/À ILCs (CD90.2 + ) were largely excluded from CPs, whereas ILCs derived from Gpr183 +/+ bone marrow (CD90.2 + ) selectively localized to CPs ( Figure 3B ). These observations demonstrate that GPR183 acts in a cell-autonomous manner to promote ILC localization to colonic CPs and ILFs.
To determine whether ILC positioning to CPs and ILFs is directed by 7a,25-OHC, we assessed the spatial distribution of ILC3s in mice lacking Ch25h. For this purpose, we reconstituted either Ch25h +/+ or Ch25h À/À recipients with bone marrow from
Rag1-deficient Rorc(gt)
GFP transgenic mice ( Figure S5C ). Immunofluorescence microscopy showed that donor-derived GFP + ILC3s localized to colonic CPs in Ch25h +/+ mice, whereas donor-derived ILC3s were unable to do so in Ch25h-deficient hosts ( Figure 3C ). In the absence of Ch25h, donor-derived ILC3s also failed to migrate to CPs in the small intestine (Figure 3D) . In contrast to in the colon, however ( Figure 3C ), host B cells in the small intestine formed enlarged lymphoid clusters, despite the ILC3 localization defect ( Figure 3D ). These findings suggest that lymphoid-tissue-inducing activity of B cells compensates for impaired ILC3 recruitment when GPR183 ligand is lacking, which subsequently allows lymphoid tissue formation in the small intestine. Combined, these data demonstrate that GPR183 and its ligand promote colonic SILT development by directing LTi-like ILC3s to sites of CP formation.
GPR183 Enhances IL-22 Production by Colonic ILC3s
Next, we asked whether altered ILC3 positioning in the absence of GPR183 causes defects in the development, homeostasis, or function of ILC3s. There was no general developmental defect, given that all ILC subsets were present in the colon of Gpr183 À/À mice ( Figures S6A and S6B ). Furthermore, flow-cytometric analysis revealed that the number of individual ILC3 subsets was not significantly different between Gpr183 +/+ mice and mice lacking Gpr183 ( Figure S6C ). We next investigated the expression of lymphotoxin, the key factor for lymphoid organogenesis. To exclude a lymphocyte source of lymphotoxin, we performed this analysis in Rag1-deficient Gpr183 À/À mice. Lymphotoxin beta (Ltb) mRNA expression in the colon was $3-fold lower in Rag1 À/À mice lacking Gpr183 than in Gpr183 Figure S6D ). CP and ILF formation is also dependent on aryl hydrocarbon receptor (AHR) (Kiss et al., 2011; Lee et al., 2011 Figure S6F ). Together, our data suggest that Gpr183 deficiency causes impaired colonic lymphoid tissue formation mainly because of the inability of LTi-like ILC3s to migrate to CPs and ILFs rather than an intrinsic defect in lymphotoxin expression by ILC3s.
ILFs are important sites of immunoglobulin A (IgA) production (Tsuji et al., 2008) , and the reduction of colonic lymphoid structures indicates that IgA production might be impaired in mice lacking Gpr183. To explore this possibility, we measured IgA in either untreated or T-cell-depleted Gpr183 +/+ and Gpr183
mice. IgA concentrations in serum and feces were not significantly different between Gpr183-deficient and Gpr183-sufficient mice ( Figure S6G ), most likely as a result of compensatory IgA production by small intestinal lymphoid structures, which were not affected by Gpr183 deficiency ( Figures 2B and 2C ). We next assessed whether Gpr183 deficiency alters the ability of ILCs to produce cytokines. IL-22 production by Gpr183-deficient ILC3s from the colon was significantly lower than production by their Gpr183 +/+ counterparts ( Figures 4A and 4B ). In contrast, IL-22 production by Gpr183-deficient ILC3s from the small intestine was unaffected ( Figures 4A and 4B ). Most likely, impaired IL-22 production by Gpr183 À/À ILC3s from the colon was secondary to the ILC3 migration defect and reduction of colonic CPs and ILFs when Gpr183 was lacking. Accordingly, 7a,25-OHC failed to directly modulate IL-22 production by ILC3s in vitro ( Figure 4C ). Moreover, the lack of Gpr183 had no effect on IL-5 and IL-17 production by intestinal ILC2s and ILC3s, respectively ( Figure 4B ). Finally, Gpr183 À/À mice (on a Rag1 À/À background) expressed less colony stimulating factor 2 (Csf2) mRNA in the colon than their Gpr183 +/+ counterparts, whereas purified Gpr183-deficient ILC3s had slightly higher Csf2 expression than Gpr183 +/+ ILC3s ( Figure 4D ). In summary, these data show that GPR183 is dispensable for IgA production but promotes IL-22 production by colonic ILC3s.
Fibroblastic Stromal Cells Provide a Local Source of 7a,25-OHC GPR183 and its ligand 7a,25-OHC directed ILC3 migration to CPs and ILFs (Figure 3 ). This allowed us to predict that production of 7a,25-OHC should take place in CPs and ILFs and thereby attract GPR183 + cells. To test this prediction, we measured 7a,25-OHC-synthesizing enzymes in micro-dissected colonic CPs and ILFs ( Figure S7A ). Consistent with our hypothesis, we found that mRNA for the GPR183-ligand-synthesizing enzymes CH25H and CYP7B1 was significantly enriched in CPs and ILFs, whereas expression of the ligand-degrading enzyme HSD3B7 was not different between the lamina propria and CPs and ILFs ( Figure 5A ). Similar results were obtained for colonic ( Figure S7B ) and Peyer's ( Figure S7C ) patches. These data suggest that local 7a,25-OHC production takes place in colonic lymphoid structures, and we therefore asked whether 7a,25-OHC promotes CP and ILF formation. To investigate this possibility, we used mice lacking Ch25h and therefore 7a,25-OHC. The number of colonic CPs and ILFs was significantly lower in Ch25h-deficient than in Ch25h +/+ mice ( Figure 5B ), demonstrating that 7a,25-OHC is essential for lymphoid organogenesis in the colon. In contrast, the formation of lymphoid structures in the small intestine and colonic patches was not affected by the absence of Ch25h ( Figure 5B ). Overall, colonic lymphoid tissue formation was less affected in Ch25h-than in Gpr183-deficient mice, most likely as a result of compensation by the alternative GPR183 ligand 7a,27-OHC, which is generated independently of CH25H (Lu et al., 2017) .
Next, we asked which signals from the microenvironment regulate 7a,25-OHC production. Among environmental factors, the microbiota plays a pivotal role in intestinal homeostasis and immunity. Using germ-free mice, we found that Gpr183, Ch25h, and Cyp7b1 mRNA expression in the colon was independent of the microbiota ( Figure 5C ). Furthermore, Ltb mRNA expression in the colon was repressed by the microbiota, consistent with the observation that, in contrast to ILF formation in the small intestine, ILF formation in the colon is inhibited by the microbiota (Buettner and Lochner, 2016; Randall and Mebius, 2014) . Accordingly, the microbiota promoted expression of C-C motif chemokine ligand 20 (Ccl20) and C-X-C motif chemokine ligand 13 (Cxcl13) mRNA only in the small intestine, but not in the colon ( Figure 5D ). Together, these data suggest that microbiota-independent local generation of 7a,25-OHC is necessary for colonic CP and ILF formation.
Finally, we aimed to identify the cellular source of the GPR183 ligand 7a,25-OHC in the colon. To distinguish between hematopoietic-and non-hematopoietic-expressed CH25H, we generated bone marrow chimeras. Ch25h +/+ recipients injected with Ch25h À/À bone marrow had colonic Ch25h mRNA expression similar to that of Ch25h +/+ mice transplanted with Ch25h +/+ bone marrow ( Figure 6A ). However, Ch25h mRNA expression in Ch25h À/À mice was not rescued by the transfer of Ch25h
bone marrow ( Figure 6A ). Similar results were obtained for the small intestine ( Figure 6A ). These findings demonstrate that hematopoietic-derived CH25H does not contribute to CH25H expression and that, instead, radio-resistant cells provide the main source of CH25H in the intestine. ) isolated from the colon ( Figure 6B ). Next, we measured expression of oxysterol-generating enzymes in different populations of colonic CD45 À cells as previously described (Stzepourginski et al., 2017) . These experiments revealed that CD34 À podoplanin (PDPN, also known as gp38) + stromal cells abundantly expressed the 7a,25-OHC-synthesizing enzymes CH25H and CYP7B1 ( Figure 6B ) and localized to ILFs ( Figure 6C ). In contrast, Figures S7D-S7F ) and expressed high amounts of Ch25h and Cyp7b1 mRNA ( Figure S7G ). These data reinforce our concept that the GPR183 ligand 7a,25-OHC is produced by fibroblastic stromal cells that reside in CPs and ILFs. We conclude that production of 7a,25-OHC by fibroblastic stromal cells provides a critical local signal for the development of lymphoid structures in the colon.
GPR183 Expression in Innate Immune Cells Promotes Colitis
Our results so far have established a role for the oxysterol-GPR183 pathway in lymphoid tissue formation in the steadystate colon. Consequently, we asked whether this pathway has a similar function during inflammation, which causes immune cell infiltration and tissue remodeling. This seemed particularly relevant given that hyperplastic lymphoid aggregates occur in human inflammatory bowel disease (IBD) (Buettner and Lochner, 2016) , and polymorphisms in Gpr183 have been associated with IBD (Jostins et al., 2012) . We first examined whether local inflammation affects the production of GPR183 ligands in the colon. For this purpose, we used a model of innate colitis in which intestinal inflammation is induced in T-and B-cell-deficient mice by the administration of an agonistic CD40 Ab . Compared with PBS-treated Rag1 À/À mice, mice treated with CD40 Ab showed rapidly increased Ch25h mRNA expression within 24 hr but repressed Hsd3b7 expression ( Figure 7A ). This pattern allowed us to predict that the amount of 7a,25-OHC in the colon would increase in response to CD40-Ab-induced inflammation. To test this prediction, we quantified GPR183 ligand activity in the colon by a bioassay based on the ligandinduced chemotaxis of the GPR183-transduced M12 B cell line (Kelly et al., 2011) . GPR183 ligand activity was induced by CD40 Ab treatment, given that the chemotactic response of GPR183-GFP + M12 cells to colon homogenates rapidly increased within 24 hr after CD40 Ab injection ( Figure 7B ). Our results suggest that colonic inflammation activates the oxysterol-GPR183 pathway through increased production of the GPR183 ligand 7a,25-OHC. Accordingly, there was a significant correlation between CH25H and CYP7B1 expression and colonic inflammation (as measured by CXCL8 expression) in humans with ulcerative colitis ( Figure 7C ).
In the CD40-Ab-induced colitis model, mobilization of ILC3s from CPs into adjacent tissue and recruitment of inflammatory monocytes (Pearson et al., 2016) result in the formation of characteristic inflammatory foci. The timing of inflammation-induced production of GPR183 ligands coincided with the movement of ILC3s out of CPs and the formation of inflammatory foci. We therefore used Rag1-deficient Gpr183 GFP/+ mice to examine whether GPR183 + cells localize to inflammatory infiltrates. Fluorescence microscopy of inflamed colon tissue showed that CD40-Ab-induced inflammatory foci at day 7 contained GPR183-expressing myeloid cells and ILCs ( Figure 7D ). These findings raise the possibility that GPR183-dependent immune cell migration promotes intestinal inflammation. To determine whether GPR183-expressing cells contribute to colitis, we treated Rag1-deficient Gpr183 À/À and littermate Gpr183 +/+ mice with CD40 Ab and assessed inflammation by histology on day 7. As expected, Gpr183 +/+ Rag1 À/À mice treated with CD40 Ab showed numerous characteristic inflammatory foci in the proximal colon ( Figure 7E ). In contrast, Rag1 À/À mice lacking Gpr183 had significantly fewer CD40-induced inflammatory infiltrates than Gpr183-sufficient controls ( Figures  7E and 7F) . Furthermore, CD40-treated Gpr183 À/À Rag1 À/À mice developed only mild colitis with an inflammation score similar to that of PBS-treated Gpr183 Figure 7F ). Overall, our data demonstrate that inflammatory signals stimulate local oxysterol production and cause colitis through GPR183-dependent activation of ILC migration, myeloid cell recruitment, and tissue remodeling.
DISCUSSION
Little is known regarding how ILCs directly sense signals from their environment and which signaling pathways enable ILCs to perform tissue remodeling. Our work demonstrates that LTi-like ILC3s were controlled by oxysterols that signal through the receptor GPR183. This instructs ILC3 positioning and lymphoid tissue formation in the colon. We propose a model where local generation of 7a,25-OHC by fibroblastic stromal cells attracts GPR183-expressing LTi-like ILC3s to sites of CP formation. This process positions LTa 1 b 2 + ILC3s for crosstalk with LTbR + stromal cells, which promotes the recruitment of GPR183-expressing B cells, to complete ILF formation. Moreover, our study provides information on the mechanisms that control the spatial and functional compartmentalization of ILC3s in the intestine. After homing to the intestine, ILC3s segregate into two distinct locations. Localization of NKp46 Yi and Cyster, 2013; Yi et al., 2012) . We have now demonstrated a role for GPR183 and oxysterols in lymphoid tissue development in the large intestine. Thus, our study has established a broader function of the oxysterol-GPR183-ligand-receptor system by linking GPR183-mediated cell positioning to tissue reorganization during steady-state homeostasis and inflammation. Whereas the signals regulating the formation of SILTs in the small intestine are well known, those in the colon have remained poorly understood. As in the small intestine, LTilike ILC3s and LTa 1 b 2 are required for colonic lymphoid organogenesis. However, the microbiota and receptor activator of NF-kB ligand (RANKL)-RANK, CXCL13-CXCR5, and CCL20-CCR6 are required for ILF development only in the small intestine (Buettner and Lochner, 2016; Randall and Mebius, 2014) . Accordingly, we have described a colon-specific pathway governing the postnatal development of lymphoid tissues. One question relates to our finding that oxysterol-GPR183 signaling is critical for CP and ILF formation in the colon but dispensable in the small intestine. GPR183 and its ligand were expressed in both the small and large intestines. Moreover, 7a,25-OHC was required for ILC3 migration to CPs not only in the colon but also in the small intestine. Despite this, lymphoid tissue development in the small intestine was normal in mice lacking 7a,25-OHC. Together, our observations indicate that, as a compensatory response, B cells form lymphoid follicles when ILC3s are unable to migrate to CPs as a result of a lack of GPR183 ligand. This notion is supported by previous studies demonstrating lymphoid-tissue-inducing activity of B cells and compensatory lymphoid tissue formation when ILC3s are absent or when LTbR signaling is blocked in utero (Buettner and Lochner, 2016) . This process must be driven by factors that operate specifically in the small intestine, because we observed compensatory B cell cluster formation only in the small intestine, but not in the colon. Such factors are the microbiota, CCL20, and CXCL13, which are all dispensable for ILC3 recruitment and CP formation but essential for B cell recruitment and ILF formation in the small intestine (Buettner and Lochner, 2016) . In conclusion, we favor the concept that the 7a,25-OHC-GPR183 pathway is active, but not absolutely required for lymphoid tissue formation, in the small intestine because other redundant factors are sufficient in the absence of GPR183 ligand.
Recent studies support the concept that dietary metabolites, such as retinoids and AHR ligands, regulate ILC3 function. These metabolites act through intracellular nuclear receptors that function as transcription factors, thereby controlling ILC activity through the stimulation of specific transcriptional programs. We have now shown that endogenous metabolites derived from cholesterol control ILC3 function by binding to a cell-surface receptor (GPR183). Previously, it was found that 7a,27-OHC and 7b,27-OHC can act as endogenous RORgt agonists and thereby regulate Th17 differentiation (Soroosh et al., 2014) . More recently, it was reported that CYP51-dependent intermediates in cholesterol biosynthesis are ligands for RORgt (Santori et al., 2015) . Chemically distinct cholesterol metabolites can therefore be sensed intracellularly through RORgt (modulating cell differentiation) and extracellularly through GPR183 (controlling ILC3 migration).
ILC3s have been implicated in gut inflammation in various mouse models of colitis (Buonocore et al., 2010; Powell et al., 2012; Vonarbourg et al., 2010) as well as in humans with IBD (Geremia et al., 2011) . Furthermore, intestinal inflammation is associated with the expansion of lymphoid structures in the gut, and hyperplastic lymphoid aggregates have been observed in human IBD (Buettner and Lochner, 2016) . We demonstrated that GPR183 promotes lymphoid tissue formation by ILC3s not only during steady state but also during inflammation. Our findings support the notion that GPR183 stimulates pro-inflammatory ILC3 activity in the colon by triggering an inflammatory migratory response that is reminiscent of the postnatal clustering of ILC3s during the formation of CPs and ILFs. Interestingly, a Gpr183 polymorphism has been associated with IBD in humans (Jostins et al., 2012) , supporting the idea that GPR183 promotes intestinal inflammation.
In summary, our study adds to our understanding of a pathway that regulates ILC3 migration, lymphoid tissue organogenesis, and colitis. GPR183 is a GPCR, a class of molecules that are involved in many diseases while being excellent drug targets. Therefore, our findings not only elucidate a molecular mechanism underlying ILC3 function but also point toward a possible therapeutic target for the treatment of human IBD.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Tim Willinger (tim.willinger@ki.se).
blocking steps, sections were stained with primary rat a-RORgt (AFKJS-9) Ab, followed by signal amplification with secondary (FITCconjugated donkey a-rat secondary Ab), tertiary (Alexa Fluor 488-conjugated rabbit a-fluorescein Ab), and quaternary (Alexa Fluor 488-conjugated donkey a-rabbit Ab) Abs. Finally, sections were co-stained with APC-conjugated a-B220 Ab. GATA3 immunofluorescence was determined using the same protocol with rat a-GATA3 (TWAJ) Ab and rat IgG2a isotype was used as a control. KLRG1 was detected with hamster a-KLRG1 (2F1) Ab and visualized with AF647-conjugated goat a-hamster IgG (ThermoFisher). Hamster IgG2a isotype was used as a control for KLRG1 staining. Images were acquired on a Nikon A1R confocal microscope and processed with NIS-Elements Imaging software.
Quantification of Intestinal CPs and ILFs
CPs and ILFs were quantified in the following gene-deficient strains:
(With the exception of Ch25h +/+ and Ch25h À/À mice, all controls were co-housed littermates.)
Colon (without cecum) and distal small intestine of 6 cm length were fixed and sectioned. Figure 2B ).
Isolation of Immune Cells and Flow Cytometry
Spleens and lymph nodes were mechanically disrupted and filtered through 100 mm nylon mesh. Lamina propria lymphocytes (LPLs) were isolated from the colon (incl. cecum) and small intestine using a standard protocol. Dissected intestines were flushed with cold PBS to remove feces and mucus, opened longitudinally, and cut into $1cm pieces. To remove epithelial cells, intestinal pieces were incubated twice in HBSS supplemented with 5% FCS, 10mM HEPES, and 5mM EDTA for 15 minutes (min) at 37 C (shaking). After each incubation, tubes were vortexed and the supernatant, containing epithelial cells, discarded. Pieces were then washed with RPMI 1640 medium supplemented with 10% FCS, 2mM L-Glutamine, 1% penicillin-streptomycin, and 55 mM b-mercaptoethanol (R10 medium), minced with scissors, and incubated in digestion medium (HBSS containing 5% FCS, 0.2mg/ml collagenase IV, and 0.1mg/ml DNase I) for 20 min at 37 C (shaking). After vortexing, supernatants were collected, and passed sequentially through 100 mm and 70 mm cell strainers. Digestion was repeated twice and the supernatants pooled. LPLs were then isolated with a 40%/ 80% Percoll gradient and washed for FACS analysis. Single-cell suspensions were stained with fluorochrome-labeled Abs (see Key Resources Table) for 20-30 min on ice. After surface staining, cells were stained with fixable viability dye-eFluor 506 (eBioscience) according to the manufacturer's instructions. Intracellular staining for RORgt (B2D)-PE-eFluor610 (eBioscience) was performed with the FoxP3 transcription factor buffer set (eBioscience). Alternatively, Rorc(gt) GFP transgenic mice were used to detect RORgt. Cells were acquired on a LSRII Fortessa flow cytometer (BD Biosciences) and analyzed with FlowJoV10 software.
LTa 1 b 2 Cell Surface Expression Surface LTa 1 b 2 was detected using a LTbR-Fc chimera (R&D Systems) as described (Bando et al., 2015) . Briefly, cells were blocked with 40 mg/ml donkey a-mouse Fab fragments (Jackson ImmunoResearch) for 20 min on ice before staining with 1 mg/ml LTbR-Fc chimera for 30 min on ice. After washing, cells were incubated for 20 min on ice with 6.5 mg/ml biotinylated donkey a-mouse IgG (Jackson ImmunoResearch). Cells were then washed, blocked with 2% mouse/rat serum, and stained with surface Ab mix including PE-conjugated streptavidin.
Intracellular Cytokine Staining
For IL-22 staining, LPLs were stimulated with 40ng/ml of recombinant IL-23 (R&D Systems) for 3 hr together with Golgi Stop (BD Biosciences). For IL-5, IL-17F and IL-17A staining, LPLs were stimulated with 100ng/ml phorbol-12-myristate 13-acetate (PMA) and 1 mg/ml Ionomycin for 3 hr in the presence of Golgi Stop at 37C, 5% CO2. Alternatively, single cell suspensions from mesenteric lymph nodes, small intestine and colon were stimulated with 20ng/ml IL-1b, 20ng/ml IL-23 and a commercially available cell stimulation cocktail (ebioscience) containing PMA, Ionomycin, Brefeldin A and Monensin in the absence (DMSO) or presence of 10nM 7a,25-OHC (Avanti Polar Lipids) for 4 hr. After stimulation, cells were first surface-stained and subsequently Table) .
Cell Sorting
Cells were isolated from the colon and small intestine as previously described (Villablanca et al., 2011) with modifications. Colon and small intestine sections were washed in PBS, cut into 1cm-pieces, and incubated with 20mL of HBSS containing 5% FCS, 5mM EDTA, 1mM DTT, and 15mM HEPES at 37 C for 30 min on a shaking incubator. The supernatant, i.e., the intestinal epithelial cell (IEC) fraction, was saved and the pieces were subsequently washed and incubated with 10mL of serum-free HBSS containing 0.15mg/mL Liberase TL (Roche) and 0.1mg/mL DNase I at 37 C for 45 min at 600rpm. The resulting lamina propria (LP) cell suspension was then passed through a 100 mm nylon mesh and centrifuged. 
Isolation of Stromal Cells
Colonic stromal cell subsets ( Figure 6B , lower panel) were isolated by cell sorting as described (Stzepourginski et al., 2017) . CXCL13 + stromal cells (Figures S7F and G) were isolated from Cxcl13-EYFP reporter mice (Onder et al., 2017) as follows: Colonic tissue was harvested and incubated three times for 15 min at room temperature under constant agitation with PBS containing 5% FCS (Lonza), 5mM EDTA (Sigma), 10mM HEPES (Sigma) and 1mM DTT (PD buffer) in order to dissociate the epithelial layer. The tissue was subsequently washed with HBSS containing 10mM HEPES and digested three times for 20 min at 37 C under constant agitation with 120mg/ml collagenase P (Roche), 25mg/ml DNase I (Applichem) and 5mg/ml Dispase I (Roche) in RPMI 1640. To enrich the fraction of stromal cells, suspensions were first purified with a 30% Percoll gradient for 20 min at 1,800rpm and 4 C. Then hematopoietic cells and erythrocytes were depleted by incubating the cell suspension with MACS a-CD45 and a-Ter119 microbeads and passing through a MACS LS column (Miltenyi Biotec). Unbound single cell suspensions were used for further flow cytometric analysis with a-CD31 (390)-PerCP/Cy5.5 and a-Podoplanin (8.1.1)-PE Abs (Biolegend) and cell sorting was performed via Bio-Rad S3 cell sorter.
Chemotaxis Assays
Splenocytes or LPLs from the colon were rested in migration medium (RPMI 1640/0.5% fatty acid-free BSA (Sigma)/10mM HEPES) for 30 min at 37 C/5% CO 2 . Migration of 1-2x10 6 input cells through 5 mM Transwells (Corning) in response to the indicated concentrations of 7a,25-OHC (Avanti Polar Lipids) was assessed after 3-4 hr. Cells in the bottom chamber were stained with fluorochrome-conjugated Abs to identify LTi- Figure 1D ). In Figure 1E , GFP transgenic mice were used and the following cell populations identified:
NK cells (B220 Figure 1D ) or as relative migration, i.e., number of cells migrated toward 7a,25-OHC compared to medium ( Figures 1E and 1F ). To measure GPR183 ligand activity, the chemotaxis of the M12 B cell line transduced with GPR183-GFP toward colon homogenates was examined as described (Kelly et al., 2011) .
IgA Production
Co-housed Gpr183 +/+ and Gpr183 À/À mice littermates were either left untreated or received a total of five intraperitoneal (i.p.) injections of 100 mg a-TCRb (H57-597) Ab (Bio X Cell) every three days. Three days after the last injection, sera and feces were collected. IgA concentrations were determined in homogenized feces and sera by sandwich ELISA using goat a-mouse IgA alpha chain Abs (Abcam). Mouse IgA kappa (Abcam) was used as a standard.
Quantitative RT-PCR Total RNA was extracted from colon tissue ($1cm piece) or purified cells with either TRIzol reagent (Invitrogen) or RNeasy Micro Kit (QIAGEN) and used for cDNA synthesis with the SuperScript First-Strand Synthesis System (Invitrogen), iScript cDNA Synthesis Kit (BioRad), or High-Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems). Quantitative RT-PCR was performed on a 7500 Fast Real-Time PCR system or PCRQuant Studio 5 Real-Time PCR system (Applied Biosystems) with primer-probe sets purchased from Applied Biosystems (Ahr, Ch25h, Ccl20, Csf2, Cxcl13, Cyp7b1, Gpr183, Hsd3b7, Lta, Ltb) or Sigma (Hprt). Alternatively, quantitative PCR was performed using Light Cycler 480 SYBR Green I Master mix (Roche Diagnosis) on a LightCycler 480 II machine (Roche Diagnosis). Expression levels were measured using following primers (Yi et al., 2012) : Ch25h Fw-GCGACGCTACAAGATCCA,
